Nabla Bio
AI-driven generative platform for de novo design of drug-like antibodies and medicines using integrated patient-relevant testing.
Informations sur l’outil
Qu'est-ce que Nabla Bio ?
Nabla Bio is an AI-driven generative platform that makes drug development a true design discipline. It combines generative de novo drug design with large-scale human-relevant testing and integrated dry/wet-lab systems to produce safer, more precise medicines that reach patients faster.
Fonctionnalités principales
Generative de novo drug design
AI-powered generation of drug candidates, including drug-like antibodies, directly from computational methods.
Patient-relevant testing integration
Combines generative design with large-scale human-relevant testing to convert trial-and-error discovery into engineerable success.
Integrated dry/wet-lab engine
Owns and unifies data, AI models, and dry/wet-lab systems to design medicines targeting binding, developability, cellular function, and in-vivo performance.
JAM-2 antibody generation
Produces drug-like antibodies straight from the computer as part of the generative design pipeline.
Cas d'utilisation
- #1
Pharmaceutical partnership drug design
Collaborative design of new medicines with leading pharmaceutical companies to bring safer and more precise drugs to patients.
- #2
Antibody and target expansion
Design of novel antibodies and medicines that unlock new targets and expand treatment frontiers.
Alternatives
Foire aux questions
What is Nabla Bio?
What does Nabla Bio's JAM-2 technology do?
Who does Nabla Bio partner with?
Where is Nabla Bio based?
Is pricing information available for Nabla Bio?
Nabla Bio Contacts et réseaux sociaux
- SociétéNabla Bio, Inc
- AdresseRiverside Technology Center 840 Memorial Dr Cambridge, MA 02139
- E-mail d'assistance
- Site Internet :
- Twitter
- LinkedIn
Avis
Partagez votre expérience avec cet outil...